½ðɳjs3833

EN
ÐÂÎÅÖÐÐÄ

»Ý¼°¸ü¶à»¼Õߣ¡ÊæËÙ´ï?·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒÄÉÈë¹ú¼ÒÒ½±£Ä¿Â¼

·¢²¼Ê±¼ä : 2024-11-29

½ðɳjs3833(ÖйúÓÎ)ÓÐÏÞ¹«Ë¾¹ÙÍø

 

11ÔÂ28ÈÕ £¬£¬£¬£¬£¬£¬¹ú¼ÒÒ½ÁƱ£ÕϾ֡¢ÈËÁ¦×ÊÔ´ºÍÉç»á±£Õϲ¿Õýʽ·¢²¼ÁË¡¶¹ú¼Ò»ù±¾Ò½ÁƱ£ÏÕ¡¢¹¤É˱£ÏÕºÍÉúÓý±£ÏÕҩƷĿ¼(2024Äê)¡·¡£¡£¡£¡£¡£ ¡£¡£ÊæËÙ´ï®·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ¾­Ì¸ÅÐÊ״α»ÄÉÈë¹ú¼ÒÒ½±£Ä¿Â¼¡£¡£¡£¡£¡£ ¡£¡£Ð°æÄ¿Â¼½«ÓÚ2025Äê1ÔÂ1ÈÕÕýʽʵʩ¡£¡£¡£¡£¡£ ¡£¡£

˵Ã÷: E:\»ôÇÉÕä\3.ÆóÒµÐû´«\3.¿¯Îï\ÄÚ¿¯\ÄÚ¿¯Îļþ\2024Äê\12Ô¿¯\10.·Çŵ±´ÌؽøÈëÒ½±£\΢ÐŽØÍ¼_20241128114133.png

 

ÊæËÙ´ï®·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ

       ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒÊô±´ÌØÀàѪ֬µ÷½ÚÒ© £¬£¬£¬£¬£¬£¬Í¨¹ýÒÖÖÆ¼«µÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥µÄÉú³É²¢Í¬Ê±Ê¹Æä·Ö½â´úлÔö¶à £¬£¬£¬£¬£¬£¬½µµÍѪµÍÃܶÈÖ¬µ°°×µ¨¹Ì´¼ºÍ¸ÊÓÍÈýõ¥£» £»£»£»£»£»£»»¹Ê¹ÔØÖ¬µ°°×A1ºÍA11Éú³ÉÔö¼Ó £¬£¬£¬£¬£¬£¬´Ó¶øÔö¸ß¸ßÃܶÈÖ¬µ°°×µ¨¹Ì´¼¡£¡£¡£¡£¡£ ¡£¡£ÊæËÙ´ï®·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒÓÅ»¯µ¨¼îÑνṹ £¬£¬£¬£¬£¬£¬¾ßÓнϺõÄË®ÈÜÐÔ £¬£¬£¬£¬£¬£¬ÏÔÖøÌáÉýÁËÉúÎïÀûÓöÈ[1]£» £»£»£»£»£»£»Ò»´ÎÒ»Á££¨135mg£©,Ò»ÌìÒ»´Î £¬£¬£¬£¬£¬£¬ÎÞÐèÓë²Íͬ·þ £¬£¬£¬£¬£¬£¬ÌáÉýÓÃÒ©±ãÀûÐÔ[2]¡£¡£¡£¡£¡£ ¡£¡£¿£¿£¿£¿£¿ £¿ÉÖ±½ÓÔÚÌåÄÚ·¢»Ó×÷Óà £¬£¬£¬£¬£¬£¬ÎÞÐè¾­¹ý¸ÎÔàÊ×¹ý´úл £¬£¬£¬£¬£¬£¬´Ó¶ø¿É½µµÍ¸ÎÔฺµ£[1]¡£¡£¡£¡£¡£ ¡£¡£ËµÃ÷ÊéÖ¸³ö £¬£¬£¬£¬£¬£¬±¾Æ·ÓëËûÍ¡ÀàÒ©ÎïÁªºÏʹÓÃÎÞÐèµ÷Õû±¾Æ·»òºÏÓÃÒ©ÎïµÄ¼ÁÁ¿¡£¡£¡£¡£¡£ ¡£¡£

 

ºÏ×÷×ÉѯÈÈÏß:4001833668

¿ÉɨÂëµÇ¼ÇºÏ×÷ÐÅÏ¢

½ðɳjs3833(ÖйúÓÎ)ÓÐÏÞ¹«Ë¾¹ÙÍø

²Î¿¼×ÊÁÏ£º

[1]     Elisavet Moutzouri ,Anastazia Kei,Moses S elisaf ,Haralampos J Milionis.Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.Vascular Health and Risk Management 2010:6 525–539.

[2]   ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ˵Ã÷Êé.

Ïà¹ØÐÂÎÅ

2025-07-02

½ðɳjs3833?±½»ÇËá°±ÂÈµØÆ½¸É»ìÐü¼ÁÈëÑ¡¹ã¶«Ê¡ÒÑ»ñÅú´´ÐÂҩе²úƷĿ¼£¨µÚÒ»Åú£©

2025-07-02

뮲´ÌæÅµÀ×£¨AR882£©È«Çò¹Ø¼üÐÔIIIÆÚREDUCE 1ÊÔÑé ÒÑÈë×鳬¹ý50%µÄÊÜÊÔÕß

2025-06-17

¹«¸æ | ½ðɳjs3833×¢ÉäÓÃßòÀ´ì¢ËáŨÈÜÒº»ñÅúÉÏÊÐ

Á˽â¸ü¶à
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿